• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Mr Michael O. Leavitt, US Health and Human Services Secretary

Our Bureau

Hyderabad, Jan. 8

The US has decided to evolve a system of safeguards to ensure safety to its citizens as it imported food and health products, keeping in mind the future needs.

While helping the host countries to set up their own drug authorities on the lines of USFDA, the apex body that monitors, regulates and gives permissions for drugs, the US is also looking at working with drug manufacturers in those countries.

Mr Michael O. Leavitt, US Secretary of Health and Human Services, said that though the present system would do for the present demands, it was not adequate for the future. There was a need for a system for the future to continue to offer safe health products to its people.

Mr Leavitt, who is leading a delegation to India, spoke to newspersons here on Tuesday, after visiting Bharat Biotech manufacturing facility at Shamirpet in the Genome Valley.

Citing the pact his country entered into with China, he said the US was going to initiate talks with the Indian Government to help evolve common safety norms.

“We are here to build bridges to achieve common goals and evolving a system for future,” he said.

He was accompanied by Mr Andrew C. von Eschenbach, Commissioner for USFDA.

Replying to a question, they said there was no plan to open a FDA office in India.

More Stories on : Health | Andhra Pradesh

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Central team to visit rain-hit areas

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line